Start-up builds PET/CT centers

Article

A new company, Morningstar Molecular Imaging, is hatching plans to launch a chain of PET/CT imaging centers across the U.S. The Sarasota, FL, firm will open its first centers in Georgia, Colorado, and Florida later this year. It plans to expand to other

A new company, Morningstar Molecular Imaging, is hatching plans to launch a chain of PET/CT imaging centers across the U.S. The Sarasota, FL, firm will open its first centers in Georgia, Colorado, and Florida later this year. It plans to expand to other states over the next 12 months. The centers will conduct business under the Morningstar Molecular Imaging name and will be jointly owned by Morningstar, local investors, and physicians where appropriate. The business model is based on three strategies: to cluster multiple imaging centers in metropolitan areas so as to establish economies of scale and local branding; provide only PET/CT through the highest performance, LSO-based scanning systems; and tie all its centers together with an IT system that supports referring physician and patient services. Key to the success of this model is a "speed-to-market" approach to ensure that the fledgling company provides service to patients in as many metro areas as soon as possible, according to Ken Manning, vice president of marketing for Morningstar.

Recent Videos
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Related Content
© 2025 MJH Life Sciences

All rights reserved.